Psychiatry Update 2021: Spring

June 15–19

CME/CE Event


Abstract submission is now open.  Submission Close Date: May 28, 2021


We invite all registered meeting attendees to submit abstracts for poster presentation on their latest research in psychiatry including Schizophrenia, Bipolar, MDD, COVID & Mental Health, Special Populations, Digital Therapeutics, and other medical psychiatry topics. A list of abstracts will be selected as oral presentations during the conference. 
All accepted abstracts will be included as an Abstract Compendium supplement to be distributed with the print version of CURRENT Psychiatry, a peer reviewed journal and INDEXED in Annals of Clinical Psychiatry. If you are returning to complete or check the status of your submission, please sign-in using your email address and password. 

Fee: no fee for abstracts not sponsored by industry; $495 per abstract for industry-sponsored abstracts.  

A portion of the proceeds from the registration and abstract fees will be donated to The Jed Foundation, a non-profit organization that protects emotional health and prevents suicide for teens and young adults in the United States, and NAMI, the National Alliance on Mental Illness, is the nation's largest grassroots mental health organization dedicated to building better lives for the millions of Americans affected by mental illness.  


Abstract Formatting and Content Guidelines 

*You must be registered for the meeting to have your abstract considered for a presentation. 

  • Language: English 

  • Authors: full last name, first name, affiliations, degrees and contact information 

  • Maximum of 3000 characters, including spaces (not including the title, authors, or affiliations) 

  • Maximum of 2 relevant tables or figures: must be 600 dpi .jpg 

  • References must be included as parenthetical in-text citations - first author, et al, journal and year - (Cruz D, et al. Blood 2012) 

  • Full contact information of corresponding author (Please ensure that your email address is accurate, as all correspondence will be sent via email) 

  • Abstract text should preferably be in a "structured abstract" form with sections marked Background, Objectives, Methods, Results, and Conclusions 

  • Abstracts containing non-generic drug names or personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted. 

*you must be registered for the meeting to have your abstract considered for a presentation. Register HERE.